# The gut-brain vagal axis governs mesolimbic dopamine dynamics and reward events

**Authors:** Oriane Onimus, Faustine Arrivet, Tinaïg Le Borgne, Sylvie Perez, Julien Castel, Anthony Ansoult, Benoit Bertrand, Nejmeh Mashhour, Camille de Almeida, Linh-Chi Bui, Marie Vandecasteele, Serge Luquet, Laurent Venance, Nicolas Heck, Fabio Marti, Giuseppe Gangarossa

PMC · DOI: 10.1126/sciadv.adz0828 · Science Advances · 2026-01-30

## TL;DR

The gut-brain vagal axis influences dopamine activity and reward processes, suggesting a broader role in motivation and reinforcement beyond the brain.

## Contribution

This study reveals that gut-brain vagal signals modulate mesolimbic dopamine dynamics and reward behavior.

## Key findings

- Gut-brain vagal tone is essential for regulating mesolimbic dopamine system activity.
- Vagal signals modulate dopamine-dependent processes and scale food- and drug-induced reinforcement.
- The findings support an integrated model of reward processing involving vagus-mediated interoceptive signals.

## Abstract

Reward processes have traditionally been ascribed to dopamine (DA)–associated circuits. While external stimuli, such as food and drugs of abuse, are activators of DA-neuron activity, growing evidence indicates that interoceptive signals also play a critical role. Among these, the gut-brain vagal axis has emerged as a key regulator, although its precise contribution to mesolimbic DA signaling and behavior remains unclear. Here, we combine complementary ex vivo and in vivo approaches across multiple scales to show that gut-brain vagal tone is essential for gating mesolimbic DA system activity and functions, modulating DA-dependent molecular and cellular processes, and scaling both food- and drug-induced reinforcement. These findings challenge the traditional brain-centric view of reward processing, supporting a more integrated model in which vagus-mediated interoceptive signals intrinsically shape motivation and reinforcement. By uncovering the influence of gut-brain vagal communication on DA functions, this work provides insights into the neurobiology of adaptive and maladaptive reward, with broad relevance for eating disorders and addiction.

Gut-brain vagal signals gate dopamine ensembles, reshaping reward and motivation beyond a brain-centric view.

## Full-text entities

- **Genes:** Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, Gria1 (glutamate receptor, ionotropic, AMPA1 (alpha 1)) [NCBI Gene 14799] {aka 2900051M01Rik, Glr-1, Glr1, GluA1, GluR-A, GluRA}, Drd2 (dopamine receptor D2) [NCBI Gene 13489] {aka D2R, Drd-2}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Pdyn (prodynorphin) [NCBI Gene 18610] {aka Dyn}, Nlrp1a (NLR family, pyrin domain containing 1A) [NCBI Gene 195046] {aka CARD7, DEFCAP, Gm14, Gm15, NAC, Nalp1}, Drd1 (dopamine receptor D1) [NCBI Gene 13488] {aka C030036C15Rik, Drd-1, Drd1a, Gpcr15}, Phox2b (paired-like homeobox 2b) [NCBI Gene 18935] {aka Dilp1, NBPhox, Pmx2b, Px2b}, Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)) [NCBI Gene 14810] {aka GluN1, GluRdelta1, GluRzeta1, M100174, NMD-R1, NMDAR1}, Tac1 (tachykinin 1) [NCBI Gene 21333] {aka 4930528L02Rik, NK-1, NK1, Nkna, PPT-A, PPTA}, Fosb (Fos B proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14282], Camk2a (calcium/calmodulin-dependent protein kinase II alpha) [NCBI Gene 12322] {aka CaMKII, mKIAA0968}, Egr3 (early growth response 3) [NCBI Gene 13655] {aka EGR-3, Pilot}, Th (tyrosine hydroxylase) [NCBI Gene 21823], Rpl19 (ribosomal protein L19) [NCBI Gene 19921], Penk (preproenkephalin) [NCBI Gene 18619] {aka ENK, PPA, Penk1}, Slc17a6 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6) [NCBI Gene 140919] {aka 2900073D12Rik, DNPI, VGLUT2}, Slc6a3 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) [NCBI Gene 13162] {aka DAT, Dat1}, Egr1 (early growth response 1) [NCBI Gene 13653] {aka A530045N19Rik, ETR103, Egr-1, Krox-1, Krox-24, Krox24}, Slc18a2 (solute carrier family 18 (vesicular monoamine), member 2) [NCBI Gene 214084] {aka 1110037L13Rik, 9330105E13, Vmat2}, Grm1 (glutamate receptor, metabotropic 1) [NCBI Gene 14816] {aka 4930455H15Rik, Gm10828, Gprc1a, mGluR1, nmf373, rcw}
- **Diseases:** catalepsy (MESH:D002375), Cataleptic (MESH:D002385), learning impairments (MESH:D007859), anxiety (MESH:D001007), weight loss (MESH:D015431), addiction (MESH:D019966), Loss of body weight (MESH:D001835), obesity (MESH:D009765), degenerative disorders (MESH:D019636), locomotor deficits (MESH:D001523), eating disorders (MESH:D001068), CPP (MESH:D000073397), binge eating (MESH:D002032)
- **Chemicals:** 5-HT (MESH:D012701), Ketofen (MESH:D007660), CO2 (MESH:D002245), Rompun (MESH:D014991), Blood glucose (MESH:D001786), polyacrylamide (MESH:C016679), insulin (MESH:D007328), pentobarbital (MESH:D010424), 4-hydroxy-3 methoxyphenylacetic acid (MESH:D006719), Hepes (MESH:D006531), Halo (MESH:D006220), noradrenaline (MESH:D009638), morphine (MESH:D009020), oil (MESH:D009821), water (MESH:D014867), KCl (MESH:D011189), isoflurane (MESH:D007530), vanillylmandelic acid (MESH:D014642), NaCl (MESH:D012965), tungsten carbide (MESH:C002802), PFA (MESH:C003043), carbon (MESH:D002244), nicotinamide mononucleotide (MESH:D009537), methylene chloride (MESH:D008752), ethylenediaminetetraacetic acid (MESH:D004492), NaHCO3 (MESH:D017693), 3,4-dihydroxyphenylacetic acid (MESH:D015102), CaCl2 (MESH:D002122), phosphocreatine (MESH:D010725), GABA (MESH:D005680), buprenorphine (MESH:D002047), O2 (MESH:D010100), Cy5 (MESH:C085321), Intralipid (MESH:C545823), Laemmli buffer (MESH:C088816), EGTA (MESH:D004533), sucrose (MESH:D013395), cholecystokinin (MESH:D002766), ATP (MESH:D000255), polyvinylidene difluoride (MESH:C024865), 3-methoxytyramine (MESH:C001746), -Adrich (-), GBR (MESH:C013003), 3-MT (MESH:C070380), perchloric acid (MESH:C576518), Na (MESH:D012964), Amph (MESH:D000661), kynurenate (MESH:D007736), MgCl2 (MESH:D015636), DA (MESH:D004298), Fluorogold (MESH:C049774), endocannabinoids (MESH:D063388), fat (MESH:D005223), biocytin (MESH:C013411), sodium acetate (MESH:D019346), GBR12909 (MESH:C043425), polyvinylpyrrolidone (MESH:D011205), tungsten (MESH:D014414), hydroxyindoleacetic acid (MESH:D006897), 3,3'-dioctadecyloxacarbocyanine perchlorate (MESH:C098044)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Gallus gallus (bantam, species) [taxon 9031]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), HLPC-ED — Mus musculus (Mouse), Hybridoma (CVCL_M036)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12857734/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12857734/full.md

## References

80 references — full list in the complete paper: https://tomesphere.com/paper/PMC12857734/full.md

---
Source: https://tomesphere.com/paper/PMC12857734